Notificação de entrada na fase nacional - PCT
#1.3
05/02/2023
RPI 2730
Application data
Number
112023005832Type
Filing
Publication
PCT
US2021052610 The application was filed at the INPI on 09/29/2021. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 05/02/2023. We update with every new RPI gazette, published weekly.
Applicants
ITERION THERAPEUTICS, INC.
US
Inventors
D. O. (pessoa física)
US
G. S. (pessoa física)
US
IPC Classification
Priority claims
US
17/037,287 · 09/29/2020
Abstract
FORMA CRISTALINA DE TEGAVIVINT, MÉTODO DE PREPARAÇÃO E USO DA MESMA. A presente invenção se refere a formas cristalinas de (9E,10E)-2,7-bis((3,5-dimetilpiperidin-1-il)sulfonil)antraceno-9,10-diona dioxima, composições farmacêuticas que compreendem a forma cristalina, processos para preparar a forma cristalina e métodos de uso para os mesmos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
05/02/2023
RPI 2730
#1.1
04/11/2023
RPI 2727
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.